Nexium capsules non-steroidal anti-inflammatory drug (NSAID) Specific Clinical Experience Investigation

Study identifier:D961HC00012

ClinicalTrials.gov identifier:NCT01562600

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with NSAIDs

Medical condition

Gastric Ulcer

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

1634

Study type

Observational

Age

N/A

Date

Study Start Date: 19 Apr 2012

Primary Completion Date: 27 Aug 2015

Study Completion Date: 27 Aug 2015

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2019 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Nexium	-

Documents available

AZ_Synopsis_D961HC00012_STUDY_REPORT_SUMMARY_revised
Download
K. Sakamoto, M. Nii, T. Tokimoto and Y. Takumi Esomeprazole (Nexium) Specific Clinical Experience Investigation for Long-term Use in the Prevention of the Recurrence of Gastric or Duodenal Ulcer with NSAIDs Jpn Pharmacol Ther, 47(7), 1043 - 1057, 2019
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

[email protected]

Investigators

Principal Investigator

Shigeru Yoshida

Astrazeneca K.K.